Annovis Bio Inc. (ANVS) option IV into data

Annovis Bio Inc. (NYSE: ANVS) 30-day option implied volatility is at 333; compared to its 52-week range of 21 to 333 into topline efficacy data for phase II/III study of buntanetap in patients with mild to moderate Alzheimer's disease is expected in April.

You May Also Be Interested In

• Uniti Group (UNIT) 3700 contracts of July 13 calls trade, share up 7%
• Intuitive Machines (LUNR) June 27.50 puts active, share price down 10%
• Woodside Energy (WDS) call put ratio 100 calls to 1 put with a focus on July 22.50 calls as share price up 5.8%